Company / Revenue
CASTLE BIOSCIENCES INC Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$344.2M
FY2025
5-year range
$94.1M / $344.2M
FY2021-FY2025
Trend
+3.7%
vs FY2024
Sector context
#127 of 155
Health Care
What the data says
CASTLE BIOSCIENCES INC's revenue of $344M is lower than 82% of companies in the Health Care sector (FY2025). Revenue has increased for 7 consecutive years, from $23M in FY2018 to $344M in FY2025.
Based on SEC 10-K filings.
$344M in FY2025 with a 5-year CAGR of +40.6%.
Improved from $220M to $344M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +35.9%
- 5-Year CAGR
- +40.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 155This company $344.2M Sector average $19.1B
▼
-98.2% below sector average
Key checks
Key Insights
- CASTLE BIOSCIENCES INC's revenue has grown for 7 consecutive years.
- 5-year CAGR of +40.6%, indicating consistent growth.
- In FY2025, revenue increased 3.7% year-over-year.
- Ranks #127 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $344.2M | +3.7% |
| FY2024 | $332.1M | +51.1% |
| FY2023 | $219.8M | +60.4% |
| FY2022 | $137.0M | +45.7% |
| FY2021 | $94.1M | +50.2% |
| FY2020 | $62.6M | +20.8% |
| FY2019 | $51.9M | +127.6% |
| FY2018 | $22.8M | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026